Local effect of topical FP-receptor agonists on retinal vessels of the ipsilateral posterior retina in normal rabbit eyes

Clinical and Experimental Ophthalmology

Volumn 36, Issue 8, 2008, Pages 767-774

  Ohashi, Masaaki ^a   Mayama, Chihiro ^b   Ishi, Kiyoshi ^b   Araie, Makoto ^c  

^a TORANOMON HOSPITAL   (Japan)

^b SAITAMA RED CROSS HOSPITAL   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Endothelin 1; Normal rabbit eye; Retinal vessel; Travoprost; Unoprostone

Indexed keywords

ANTIGLAUCOMA AGENT; ENDOTHELIN 1; INDOMETACIN; PROSTAGLANDIN; TRAVOPROST; UNCLASSIFIED DRUG; UNOPROSTONE; UNOPROSTONE ISOPROPYL ESTER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ENZYME INHIBITION; EVENING DOSAGE; EXPERIMENTAL RABBIT; INTRAOCULAR PRESSURE; MORNING DOSAGE; NONHUMAN; PULSE RATE; RETINA BLOOD VESSEL; SPHYGMOMANOMETER; TREATMENT DURATION; TREATMENT RESPONSE; VASOCONSTRICTION;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CLOPROSTENOL; DINOPROST; ENDOTHELIN-1; HEART RATE; INDOMETHACIN; INTRAOCULAR PRESSURE; OPHTHALMIC SOLUTIONS; RABBITS; RETINAL VESSELS; TIME FACTORS; VASOCONSTRICTION;

EID: 58149333492     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2008.01898.x     Document Type: Article

References (50)

1. Thylefors B, Negrel AD, Pararajasegaram R, Dadzie KY. Global data on blindness. Bull World Health Organ 1995; 73: 115-21.
2. Foster A, Johnson G. Blindness in the developing world. Br J Ophthalmol 1993; 77: 398-9.
3. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol 1996; 80: 389-93.
4. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006; 90: 262-7.
5. Bonomi L, Marchini G, Marraffa M, Bernardi P, Morbio R, Varotto A. Vascular risk factors for primary open angle glaucoma: The Egna-Neumarkt Study. Ophthalmology 2000; 107: 1287-93.
6. Cioffi GA, Sullivan P. The effect of chronic ischemia on the primate optic nerve. Eur J Ophthalmol 1999; 9 (Suppl. 1): S34-6.
7. Fuchsjager-Mayrl G, Wally B, Georgopoulos M et al. Ocular blood flow and systemic blood pressure in patients with primary open-angle glaucoma and ocular hypertension. Invest Ophthalmol Vis Sci 2004; 45: 834-9.
8. Hayreh SS, Zimmerman MB, Podhajsky P, Alward WL. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol 1994; 117: 603-24.
9. Satilmis M, Orgul S, Doubler B, Flammer J. Rate of progression of glaucoma correlates with retrobulbar circulation and intraocular pressure. Am J Ophthalmol 2003; 135: 664-9.
10. Kondo Y, Niwa Y, Yamamoto T, Sawada A, Harris A, Kitazawa Y. Retrobulbar hemodynamics in normal-tension glaucoma with asymmetric visual field change and asymmetric ocular perfusion pressure. Am J Ophthalmol 2000; 130: 454-60.
11. Sharif NA, Davis TL, Williams GW. [3H]AL-5848 ([3H]9beta-(+)-Fluprostenol). Carboxylic acid of travoprost (AL-6221), a novel FP prostaglandin to study the pharmacology and autoradiographic localization of the FP receptor. J Pharm Pharmacol 1999; 51: 685-94.
12. Hellberg MR, Sallee VL, McLaughlin MA etal. Preclinical efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist. J Ocul Pharmacol Ther 2001; 17: 421-32.
13. Parrish RK, Palmberg P, Sheu WP. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: A 12-week, randomized, masked-evaluator multicenter study. Am J Ophthalmol 2003; 135: 688-703.
14. Przydryga JT, Egloff C. Intraocular pressure lowering efficacy of travoprost. Eur J Ophthalmol 2004; 14: 416-22.
15. Sharif NA, Kelly CR, Crider JY. Agonist activity of bimatoprost, travoprost, latanoprost, unoprostone isopropyl ester and other prostaglandin analogs at the cloned human ciliary body FP prostaglandin receptor. J Ocul Pharmacol Ther 2002; 18: 313-24.
16. Ota T, Aihara M, Narumiya S, Araie M. The effects of prostaglandin analogues on IOP in prostanoid FP-receptor-deficient mice. Invest Ophthalmol Vis Sci 2005; 46: 4159-63.
17. Ishii K, Tomidokoro A, Nagahara M etal. Effects of topical latanoprost on optic nerve head circulation in rabbits, monkeys, and humans. Invest Ophthalmol Vis Sci 2001; 42: 2957-63.
18. McKibbin M, Menage MJ. The effect of once-daily latanoprost on intraocular pressure and pulsatile ocular blood flow in normal tension glaucoma. Eye 1999; 13: 31-4.
19. Sponsel WE, Mensah J, Kiel JW etal. Effects of latanoprost and timolol-XE on hydrodynamics in the normal eye. Am J Ophthalmol 2000; 130: 151-9.
20. Geyer O, Man O, Weintraub M, Silver DM. Acute effect of latanoprost on pulsatile ocular blood flow in normal eyes. Am J Ophthalmol 2001; 131: 198-202.
21. Tamaki Y, Nagahara M, Araie M, Tomita K, Sandoh S, Tomidokoro A. Topical latanoprost and optic nerve head and retinal circulation in humans. J Ocul Pharmacol Ther 2001; 17: 403-11.
22. Poinoosawmy D, Indar A, Bunce C, Garway-Heath DF, Hitchings RA. Effect of treatment by medicine or surgery on intraocular pressure and pulsatile ocular blood flow in normal-pressure glaucoma. Graefes Arch Clin Exp Ophthalmol 2002; 240: 721-6.
23. Sponsel WE, Paris G, Trigo Y, Pena M. Comparative effects of latanoprost (Xalatan) and unoprostone (Rescula) in patients with open-angle glaucoma and suspected glaucoma. Am J Ophthalmol 2002; 134: 552-9.
24. Inan UU, Ermis SS, Orman A et al. The comparative cardiovascular, pulmonary, ocular blood flow, and ocular hypotensive effects of topical travoprost, bimatoprost, brimonidine, and betaxolol. J Ocul Pharmacol Ther 2004; 20: 293-310.
25. Makimoto Y, Sugiyama T, Kojima S, Azuma I. Long-term effect of topically applied isopropyl unoprostone on microcirculation in the human ocular fundus. Jpn J Ophthalmol 2002; 46: 31-5.
26. Tamaki Y, Araie M, Tomita K, Nagahara M, Sandoh S, Tomidokoro A. Effect of topical unoprostone on circulation of human optic nerve head and retina. J Ocul Pharmacol Ther 2001; 17: 517-27.
27. Yu DY, Su EN, Cringle SJ, Schoch C, Percicot CP, Lambrou GN. Comparison of the vasoactive effects of the docosanoid unoprostone and selected prostanoids on isolated perfused retinal arterioles. Invest Ophthalmol Vis Sci 2001; 42: 1499-504.
28. Polska E, Doelemeyer A, Luksch A et al. Partial antagonism of endothelin 1-induced vasoconstriction in the human choroid by topical unoprostone isopropyl. Arch Ophthalmol 2002; 120: 348-52.
29. 2+ antagonist: Ocular and periocular penetration after instillation. Invest Ophthalmol Vis Sci 2003; 44: 1169-77.
30. Ichikawa M, Okada Y, Asai Y, Hara H, Ishii K, Araie M. Effects of topically instilled bunazosin, an alpha1-adrenoceptor antagonist, on constrictions induced by phenylephrine and ET-1 in rabbit retinal arteries. Invest Ophthalmol Vis Sci 2004; 45: 4041-8.
31. Mizuno K, Koide T, Yoshimura M, Araie M. Neuroprotective effect and intraocular penetration of nipradilol, a beta-blocker with nitric oxide donative action. Invest Ophthalmol Vis Sci 2001; 42: 688-94.
32. Florey H, Marvin HM. The blood-pressure reflexes of the rabbit under urethane anaesthesia. J Physiol 1928; 64: 318-23.
33. Parys-Van Ginderdeuren R, Malcolm D, Varma DR, Aranda JV, Chemtob S. Dissociation between prostaglandin levels and blood flow to the retina and choroid in the newborn pig after nonsteroidal antiinflammatory drugs. Invest Ophthalmol Vis Sci 1992; 33: 3378-84.
34. Kimura T, Yoshida Y, Toda N. Mechanisms of relaxation induced by prostaglandins in isolated canine uterine arteries. Am J Obstet Gynecol 1992; 167: 1409-16.
35. Taniguchi T, Haque MS, Sugiyama K, Hori N, Kitazawa Y. Ocular hypotensive mechanism of topical isopropyl unoprostone, a novel prostaglandin metabolite-related drug, in rabbits. J Ocul Pharmacol Ther 1996; 12: 489-98.
36. Yousufzai SY, Ye Z, Abdel-Latif AA. Prostaglandin F2 alpha and its analogs induce release of endogenous prostaglandins in iris and ciliary muscles isolated from cat and other mammalian species. Exp Eye Res 1996; 63: 305-10.
37. Kashiwagi K, Kanai N, Tsuchida T et al. Comparison between isopropyl unoprostone and latanoprost by prostaglandin E(2)induction, affinity to prostaglandin transporter, and intraocular metabolism. Exp Eye Res 2002; 74: 41-9.
38. Mizuno K, Koide T, Saito N et al. Topical nipradilol: Effects on optic nerve head circulation in humans and periocular distribution in monkeys. Invest Ophthalmol Vis Sci 2002; 43: 3243-50.
39. Silldorff EP, Yang S, Pallone TL. Prostaglandin E2 abrogates endothelin-induced vasoconstriction in renal outer medullary descending vasa recta of the rat. J Clin Invest 1995; 95: 2734-40.
40. Berti F, Rossoni G, Biasi G, Buschi A, Mandelli V, Tondo C. Defibrotide, by enhancing prostacyclin generation, prevents endothelin-1 induced contraction in human saphenous veins. Prostaglandins 1990; 40: 337-50.
41. Sugiyama T, Moriya S, Oku H, Azuma I. Association of endothelin-1 with normal tension glaucoma: Clinical and fundamental studies. Surv Ophthalmol 1995; 39 (Suppl. 1): S49-56.
42. Kaiser HJ, Flammer J, Wenk M, Luscher T. Endothelin-1 plasma levels in normal-tension glaucoma: Abnormal response to postural changes. Graefes Arch Clin Exp Ophthalmol 1995; 233: 484-8.
43. Thieme H, Schimmat C, Munzer G etal. Endothelin antagonism: Effects of FP receptor agonists prostaglandin F2alpha and fluprostenol on trabecular meshwork contractility. Invest Ophthalmol Vis Sci 2006; 47: 938-45.
44. 2+] i by antiglaucoma drugs in cultured A7r5 vascular smooth-muscle cells. J Ocul Pharmacol Ther 2004; 20: 201-9.
45. Thieme H, Steinhausen K, Ottlecz A et al. Effects of unoprostone and endothelin 1 on L-type channel currents in human trabecular meshwork cells. Ophthalmic Res 2005; 37: 293-300.
46. Polak K, Luksch A, Frank B, Jandrasits K, Polska E, Schmetterer L. Regulation of human retinal blood flow by endothelin-1. Exp Eye Res 2003; 76: 633-40.
47. Cellini M, Possati GL, Profazio V et al. Color Doppler imaging and plasma levels of endothelin-1 in low-tension glaucoma. Acta Ophthalmol Scand Suppl 1997; 224: 11-13.
48. Grover S, Apushkin MA, Fishman GA. Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa. Am J Ophthalmol 2006; 141: 850-8.
49. Maren TH, Conroy CW, Wynns GC, Levy NS. Ocular absorption, blood levels, and excretion of dorzolamide, a topically active carbonic anhydrase inhibitor. J Ocul Pharmacol Ther 1997; 13: 23-30.
50. Okada Y, Ichikawa M, Ishii K, Hara H. Effects of topically instilled bunazosin hydrochloride and other ocular hypotensive drugs on endothelin-1-induced constriction in rabbit retinal arteries. Jpn J Ophthalmol 2004; 48: 465-9.